Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.19.3
Shareholders' Deficit (Tables)
 9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Schedule of nonvested activity
   

Number of

Non-vested Shares

     Weighted Average Grant Date Fair Value  
Non-vested, December 31, 2018     5,998,672     $ 0.61  
Granted     10,700,000       0.05  
Shares vested     (323,373 )     (0.85 )
Forfeited     -       -  
Non-vested, September 30, 2019     16,375,299     $ 0.24  
Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding, December 31, 2018     11,445,698     $ 0.30                  
Granted     -       -                  
Exercised     -       -                  
Forfeited     -       -                  
Balance Outstanding, September 30, 2019     11,445,698     $ 0.30       5.86     $ 50,400  
Exercisable, September 30, 2019     10,401,862     $ 0.30       5.64     $ 50,400  
Schedule of warrant activities
    Number of Warrants     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding December 31, 2018     -     $ -       -     $ -  
Granted     1,750,000       0.09                  
Cancelled     -       -                  
Balance Outstanding September 30, 2019     1,750,000     $ 0.09       4.84     $ 0  
Exercisable, September 30, 2019     1,750,000     $ 0.09       4.84     $ 0